Add like
Add dislike
Add to saved papers

Comparison of the SenSmart™ and the INVOS™ neonatal cerebral near-infrared spectrometry devices.

OBJECTIVES: To determine the correlation and agreement between the SenSmart™ and the INVOS™ devices of neonatal cerebral regional oxygen saturation (CrSO2 ) measurements using neonatal sensors. The secondary objective was to develop a regression model that predicts CrSO2 -INVOS values using CrSO2 -SenSmart indices and determine whether the values between the devices are interchangeable.

METHODS: A prospective, cross-sectional study was conducted in infants during the first 4 weeks of life. Simultaneous, bilateral CrSO2 was measured using the SenSmart™X100 (CrSO2 -SenSmart) or INVOS™ 5100C (CrSO2 -INVOS) device in each frontoparietal area for 2 h. Five-minute CrSO2 values were extracted for analysis.

RESULTS: Thirty infants were recruited with 720 pairwise measurements and 26 (84%) were evaluated in the first week of life. Mean gestational age of the preterm and term infants was [30.9 ± 2.8 ( n  = 14) and 38.8 ± 1.1 ( n  = 16)] weeks, respectively. Overall CrSO2 - was 77.08 ± 9.70% and 71.45 ± 12.74% for the SenSmart and INVOS, respectively ( p  < 0.001). The correlation coefficient ( r ) between the CrSO2 -SenSmart and INVOS was 0.20 ( p  < 0.001). The mean difference between the CrSO2 -SenSmart and INVOS was 5.63 ± 13.87% with -21.6% to 32.8% limits of agreement. The r and mean difference was 0.39 ( p  < 0.001) and 8.87 ± 12.58% in preterm infants, and 0.06 ( p  = 0.27) and 2.79 ± 14.34 in term infants.

CONCLUSION: The CrSO2 -SenSmart tended to read higher than the CrSO2 -INVOS device. There was no correlation between the CrSO2 -SenSmart and the CrSO2 -INVOS in term infants and it was weak in preterms. Due to imprecise agreement, the CrSO2 -SenSmart values are not interchangeable with those of the CrSO2 -INVOS.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.
Urinary Tract Infections: Core Curriculum 2024.American Journal of Kidney Diseases 2023 October 31

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app